Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

QLT and Kinetek establish research and license agreement for signal transduction inhibitors

June 11, 2001

Several ARVO presentations cover preclinical and early clinical profile of AL-6598

May 16, 2001

Cannabinoid receptor agonist reduces IOP in monkeys with and without glaucoma

May 15, 2001

BPI-derived compounds show promise for Rx of pathological retinal neovascularization

May 9, 2001

ARVO 2001 presentations underline promise of squalamine in angiogenic eye diseases

May 9, 2001

Inspire reports progress for two ophthalmic products at ARVO

May 9, 2001

Sustained benefits seen for Visudyne therapy over three years of follow-up

May 8, 2001

Additional trial results reported for CAT's ocular agent CAT-152

May 4, 2001

Anika receives premarket approval from FDA for Staarvisc ophthalmic product

May 4, 2001

Ocular medications from Alcon with improved profile compared to PGF2alpha

April 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.